Evidence map›Paper›PMID 34733959›Full record

ArticleAnnals of translational medicine2021

Safflower yellow pigment and Sanqi

Yang Li, Yan Lin, Zhixiang Shi, Yuxuan Hu, Taihang Shao, Mengyuan Li, Jiawen Zhu, Lizhou Sun, Feng Chang

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Annals of translational medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.3field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Yang LiSchool of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, China.
Yan LinSchool of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China.
Zhixiang ShiSchool of Foreign Languages, China Pharmaceutical University, Nanjing, China.
Yuxuan HuSchool of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, China.
Taihang ShaoSchool of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, China.
Mengyuan LiSchool of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China.
Jiawen ZhuInstitute of Pharmaceutical Sciences, China Pharmaceutical University, Nanjing, China.
Lizhou SunDepartment of Obstetrics and Gynecology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Feng ChangSchool of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, China.
China Pharmaceutical University · CNJiangsu Province Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSanqi

methodsChina National Knowledge Infrastructure (CNKI), Wanfang, SinoMed, VIP, PubMed, Embase, and the Chinese Biomedical Literature (CBM) were searched with the restrictions keywords in Chinese and English between 2006 and 2019 to obtain RCTs. A meta-analysis and a meta-regression analysis were undertaken in Reviewer Manager 5.3 software to compare the efficacy and safety of Sanqi

resultsTwelve papers were all randomized controlled trials (RCTs) in which Sanqi

conclusionsComparing with Sanqi

Indexed as

cerebral infarctioncost-effectiveness analysismeta-analysissafflower injectionSafflower yellow pigment

Identifiers

PMID34733959
PMCPMC8506788
OpenAlexW3197099578

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.